The European Medicines Agency has accepted only four of the 15 applications received so far under its early interaction pilot, which offers free scientific advice to drug companies in an effort to stimulate pediatric development1,2.
Mixed Results For EMA's Early Pediatric Advice Pilot
The European Medicines Agency has accepted only four of the 15 applications received so far under its early interaction pilot, which offers free scientific advice to drug companies in an effort to stimulate pediatric development1,2.
More from Archive
More from Pink Sheet
• By
A new chapter that will be published in the European Pharmacopoeia soon is expected to provide a comprehensive framework for the production and quality control of cell-based preparations. Meanwhile, an existing chapter has been revised to facilitate the implementation of rapid microbiological testing methods.
• By
The preliminary White House 2026 budget plan cuts agency funding, but not so sharply that user fees are excluded from collection.
• By
An investigation by the US Secretary of Commerce into pharmaceutical imports gives industry an opportunity to comment. AAM CEO John Murphy talked to Pink Sheet's sister publication Scrip about the latest developments.